Market Overview:
The global potassium citrate market size reached US$ 722.7 Million in 2022. Looking forward, IMARC Group expects the market to reach US$ 927.8 Million by 2028, exhibiting a growth rate (CAGR) of 4% during 2023-2028.
Report Attribute
|
Key Statistics
|
Base Year
|
2022
|
Forecast Years
|
2023-2028
|
Historical Years
|
2017-2022
|
Potassium Citrate Market Size in 2022 |
US$ 722.7 Million |
Potassium Citrate Market Forecast in 2028 |
US$ 927.8 Million |
Potassium Citrate Market Growth Rate 2023-2028 |
4% |
Potassium citrate (K3C6H5O7) or tri-potassium citrate, refers to a white, odorless, citric, hygroscopic crystalline powder that is manufactured by combining potassium bicarbonate and citric acid. It acts as an essential mineral for maintaining body fluid volume, regulating cell function, and balancing electrolytes. This, in turn, helps in treating kidney stone conditions, reducing the risk of metabolic ailments, producing alkalizing effects in the body for balancing urinary pH levels, maintaining a healthy heart, and controlling muscle and nerve function.
.webp)
Potassium Citrate Market Trends:
The widespread adoption of potassium citrate across various industrial verticals, such as pharmaceutical, cosmetics, and food and beverage (F&B), as an alternative to sodium citrate is one of the prime factors primarily driving the market growth. This is further supported by the rising demand for a healthy diet and increasing health consciousness amongst consumers regarding the increasing prevalence of heart disorders caused due to the consumption of sodium in excessive amount. In line with this, the extensive product utilization as an emulsifying agent for achieving soft crumb structure and enhancing shelf life of various baked and confectionery items is acting as another growth-inducing factor. Moreover, the escalating investments made by the government of various countries in research and development (R&D) activities for introducing diuretics as a clinical medicine to reduce the fluid level in the human body without losing potassium is contributing to the market growth. Potassium citrate also functions as an electrolyte replenisher, protein supplement, excipient, and antiacid, which, in turn, is facilitating their widespread adoption across the healthcare sector. Apart from this, strategic collaborations amongst the key players for launching advanced, potassium-nitrate infused personal care products to extend their existing brand portfolio is creating a positive outlook for the market.
Note: Information in the above chart consists of dummy data and is only shown here for representation purpose. Kindly contact us for the actual market size and trends.
Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each sub-segment of the global potassium citrate market report, along with forecasts at the global, regional and country level from 2023-2028. Our report has categorized the market based on type, function and end user.
Breakup by Type:
Breakup by Function:
Note: Information in the above chart consists of dummy data and is only shown here for representation purpose. Kindly contact us for the actual market size and trends.
- Acidulant
- Emulsifier
- Stabilizer
- Antioxidants
- Others
Breakup by End User:
- Food and Beverages
- Pharmaceuticals
- Personal Care
- Others
Breakup by Region:
To get more information on the regional analysis of this market, Request Sample
- North America
- Asia-Pacific
- China
- Japan
- India
- South Korea
- Australia
- Indonesia
- Others
- Europe
- Germany
- France
- United Kingdom
- Italy
- Spain
- Russia
- Others
- Latin America
- Middle East and Africa
Competitive Landscape:
The competitive landscape of the industry has also been examined along with the profiles of the key players being Archer-Daniels-Midland Company, ATPGroup, Cargill Incorporated, Dr. Paul Lohmann GmbH & Co. KGaA, FBC Industries, Foodchem International Corporation, Gadot Biochemical Industries Ltd., Huangshi Xinghua Biochemical Co. Ltd., Jiangsu Mupro IFT Corp., Jungbunzlauer Suisse AG, Niran BioChemical Limited, RZBC Group Co. Ltd. and Tate & Lyle PLC.
Report Coverage:
Report Features |
Details |
Base Year of the Analysis |
2022 |
Historical Period |
2017-2022 |
Forecast Period |
2023-2028 |
Units |
US$ Million |
Segment Coverage |
Type, Function, End User, Region |
Region Covered |
Asia Pacific, Europe, North America, Latin America, Middle East and Africa |
Countries Covered |
United States, Canada, Germany, France, United Kingdom, Italy, Spain, Russia, China, Japan, India, South Korea, Australia, Indonesia, Brazil, Mexico |
Companies Covered |
Archer-Daniels-Midland Company, ATPGroup, Cargill Incorporated, Dr. Paul Lohmann GmbH & Co. KGaA, FBC Industries, Foodchem International Corporation, Gadot Biochemical Industries Ltd., Huangshi Xinghua Biochemical Co. Ltd., Jiangsu Mupro IFT Corp., Jungbunzlauer Suisse AG, Niran BioChemical Limited, RZBC Group Co. Ltd. and Tate & Lyle PLC. |
Customization Scope |
10% Free Customization |
Report Price and Purchase Option |
Single User License: US$ 2499
Five User License: US$ 3499
Corporate License: US$ 4499 |
Post-Sale Analyst Support |
10-12 Weeks |
Delivery Format |
PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request) |